分娩时甲基苯丙胺尿检阳性与不良围产结局相关
单中心回顾性队列研究纳入2015年分娩时行尿药筛查的患者,比较甲基苯丙胺阳性组与阴性对照组。阳性组无或有限产前保健更常见,两组均存在多药使用。阳性组胎盘早剥、早产、1分钟和5分钟Apgar评分降低及围产期死亡风险均升高。
核心结论
- 分娩入院时甲基苯丙胺尿检阳性与显著的母儿发病率和死亡率相关,包括胎盘早剥、早产和围产期死亡风险增加。
研究设计与样本
- 单中心回顾性队列研究,时间范围为2015年1月至12月,从电子病历中识别分娩时记录尿药筛查的患者,比较甲基苯丙胺阳性组与阴性对照组。
主要发现
- 两组人口学特征(年龄、多产次、种族)相似,但阳性组更可能无或仅有有限产前保健,且两组均存在多药使用。
- 阳性组未显示母体高血压疾病风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of methamphetamine use in reproductive-age women across the United States is increasing. The existing literature on methamphetamine use in pregnancy has indicated an elevated risk of adverse maternal and neonatal health outcomes. OBJECTIVE: This study aimed to investigate pregnancy outcomes in patients with recent methamphetamine use compared with patients who received negative test results for methamphetamine at the time of delivery. STUDY DESIGN: A single-site retrospective cohort study from January to December 2015 was performed. Patients with a documented urine drug screen during the delivery encounter were identified from the electronic medical records. The outcomes of patients with methamphetamine-positive urine drug screens were compared with controls with urine drug screens negative for methamphetamine. Maternal outcomes of interest included placental abruption, hypertensive disorders, premature preterm rupture of membranes, postpartum hemorrhage, and preterm birth. Utilization of prenatal care, social work consults, and child protective services referrals were also recorded. Neonatal outcomes included birthweight, neonatal intensive care unit length of stay, Apgar scores, and perinatal mortality. RESULTS: The 2 groups had similar demographic characteristics (age, multiparity, ethnicity), with the methamphetamine-positive group more likely to have no or limited prenatal care. Both groups engaged in polysubstance use. A methamphetamine-positive urine drug screen at the time of delivery carries an increased risk of abruption (odds ratio, 5.63; confidence interval, 1.21-26.21) but indicated no increased risk of maternal hypertensive disorders. Additional associated risks include preterm birth (odds ratio, 3.10; confidence interval, 1.44-6.68), lower Apgar scores at 1 and 5 minutes (P=.012 and P=.02, respectively), and increased perinatal mortality (odds ratio, 6.9; confidence interval, 1.01-47.4). CONCLUSION: Positive urine drug testing for methamphetamines during labor admission confers considerable maternal and perinatal morbidity and mortality including an increased risk of placental abruption, preterm birth, and perinatal demise. Given the limited treatments for methamphetamine addiction, further research is urgently needed.
引用
- Pham T, Tinajero Y, Mo L, et al. Obstetrical and perinatal outcomes of patients with methamphetamine-positive drug screen on labor and delivery. Am J Obstet Gynecol MFM. 2020. PMID: 33345915. doi:10.1016/j.ajogmf.2020.100195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。